Sanofi Aventis Group,   

MIBP vaccine

Suspension for intramuscular injection, 0.5 ml / dose.

MIBP vaccine

Lyophilizate for the preparation of solution for intramuscular and subcutaneous administration complete with a sodium chloride solution 0.4% 1 dose.

Antiallergic agent - H1-histamine receptor blocker

Tablets, film-coated, 120 mg and 180 mg.

hypoglycemic agent for oral administration combined (biguanide + sulfonylurea derivative).
Tablets, film-coated, 1 mg + 250 mg and 2 mg + 500 mg.
Hypoglycemic agent - short-acting insulin analog

Solution for subcutaneous administration, 100 U / ml.

angiotensin II receptor antagonist

Film-coated tablets, 150 mg and 300 mg.

Immunosuppressive remedy

Tablets coated with 10 mg, 20 mg and 100 mg.

MIBP is an eubiotic. Antidiarrheal microorganisms
Capsules.
Antifungal medication for external use

Cream for external use 1%.

Non-steroidal anti-inflammatory drug
Solution for topical application 0,15%.

Non-steroidal anti-inflammatory drug
Spray for topical use dosed with 0.27 mg / dose.

Expectorant of plant origin
Syrup.
Expectorant of plant origin
Elixir.
Leukopoiesis stimulant
Liofilizate for the preparation of a solution for intravenous and subcutaneous injection of 33.6 million. ME (263 μg).
Gonadotropic hormone secretion inhibitor

Capsules, 100 mg and 200 mg.

antiepileptic agent

Lyophilizate for the preparation of a solution for intravenous administration, 400 mg (complete with a solvent).

Antiepileptic remedy

Syrup, 57.64 mg / ml.

Antiepileptic remedy

The tablets of the prolonged action covered with a cover, 300 mg and 500 mg.

Antiepileptic remedy

Granules of prolonged action, 100 mg, 250 mg, 500 mg, 750 mg and 1000 mg.

Antiepileptic remedy

Intestine-soluble film coated tablets, 300 mg.

Antitumor agent - alkaloid

Concentrate for the preparation of a solution for infusions, 40 mg / ml (complete with a solvent).

Sleeping pills. Psychotropic substance listed in List III of the "List of narcotic drugs, psychotropic substances and their precursors subject to control in the Russian Federation".

Tablets, film-coated, 10 mg.

MIBP vaccine

Suspension for intramuscular and subcutaneous administration, 0.5 ml / dose.

Sleeping pills.

Tablets, film-coated 7.5 mg

hypoglycemic agent - long-acting insulin analog

Solution for subcutaneous administration, 100 units / ml.

hypoglycemic agent - medium-duration insulin

Suspension for subcutaneous administration, 100 IU / ml.

A hypoglycemic agent is a combination of insulin of short and medium duration

Suspension, 40 IU / ml and 100 IU / ml.

hypoglycemic agent - short-acting insulin
Solution for injection, 100 IU / ml.
Anticoagulant means of direct action
Solution for Injection 2000 anti-Ha IU / 0.2 ml; 4000 anti-Ha IU / 0.4 mL; 6000 anti-Ha IU / 0.6 mL; 8000 anti-Ha IU / 0.8 ml; 10,000 anti-Ha IU / 1 ml.
Hypotensive drug combined (diuretic + angiotensin II receptor antagonist).
Tablets, film-coated, 12.5 mg + 150 mg and 12.5 mg + 300 mg.
Hypotensive combined agent (angiotensin II receptor antagonist [ARA II] + diuretic)
Film-coated tablets, 300 mg / 25 mg.
Hypotensive combined agent (angiotensin II receptor antagonist [ARA II] + diuretic)
Tablets 150 mg / 12.5 mg and 300 mg / 12.5 mg.
Common Toning Agent
Solution for oral administration 25 mg / ml.
Antiaggregant agent
Tablets, film-coated, 100 mg + 75 mg.
Vasodilating agent
Tablets of 4 mg.
hypoglycemic agent - long-acting insulin analog

Solution for subcutaneous administration, 100 units / ml.

Antitussive remedy of peripheral action

Tablets, 100 mg.

Mucolytic agent

Syrup for children, 20 mg / ml.

A hypoglycemic agent, a glucagon-like receptor polypeptide, an agonist

The solution for subcutaneous administration was 0.05 mg / ml (10 μg / dose) and 0.1 mg / ml (20 μg / dose).

HYPOTHENNE COMBINED MEANS (angiotensin II receptor antagonist + diuretic)
Tablets, film-coated, 50 mg / 12.5 mg.
beta1-blocker selective

Tablets, film-coated, 20 mg.

Antacid agent

Suspension for oral administration in bags (sachets), 15 ml.

Antacid agent
Tablets are chewable. Tablets are chewable [without sugar].
Antacid agent
Suspension for oral administration [with a taste of lemon], suspension for oral administration [with the taste of black currant].
Magnesium preparation
The tablets covered with a cover.
Solution for oral administration.
Enzyme agent
Lyophilizate in an amount equivalent to 50 mg of the active substance.
MIBP vaccine

Solution for intramuscular injection, 0.5 ml / dose.

Hypoglycemic agent for oral administration of the biguanide group.
Tablets, film-coated, 500 mg, 850 mg and 1000 mg.
Immunostimulating agent

A solution for subcutaneous administration of 20 mg / ml.

Antiarrhythmic agent.
Tablets, film-coated, 400 mg.
antipsychotic agent (antipsychotic)

Solution for oral administration 4%.

Bottles of 30 ml.

30 ml per bottle of dark neutral glass (type III) with a dropper. By 1 A bottle together with the instructions for application in a cardboard box.

Bottle of 125 ml.

For 125 ml in a bottle of dark neutral glass (type III) complete with a plastic syringe-dispenser. 1 bottle with instructions for use in a cardboard box.

Capsules 10 mg.

For 10 capsules in a blister of PVC / aluminum foil. For 5 blisters together with instructions for use in a cardboard box.

5-alpha reductase inhibitor
Tablets, film-coated, 5 mg.
An anticongestive agent of plant origin.
Cream nasal.
An anticongestive agent of plant origin.
Ointment nasal.
antiplatelet agent

Film-coated tablets, 300 mg.

antiplatelet agent

Tablets coated with a film coating, 75 mg.

MIBP vaccine

Solution for intramuscular and subcutaneous injection, 0.5 ml / dose.

A fully humanized monoclonal antibody (IgG1). Protein convertase inhibitor subtilisin-kexin type 9 (PCSK9)

A solution for subcutaneous administration is 75 mg / ml and 150 mg / ml.

hemorrhoids treatment

Ointment for topical application.

Hemorrhoids treatment.

Rectal capsules.

20 capsules in a bottle of dark glass, with a screw cap.

1 bottle with instructions for use in a cardboard box.

anti-tuberculosis drug

Film-coated tablets.

antibiotic, macrolide.
Film-coated tablets, 150 mg.
glucocorticosteroid for topical use + antibiotics (aminoglycoside and cyclic polypeptide)
Eye and ear drops.
Antimicrobial agent - fluoroquinolone
Tablets, film-coated, 250 mg, 500 mg.
Antimicrobial agent - fluoroquinolone

Solution for infusions 5 mg / ml.

antitumor agent - alkaloid

Concentrate for solution for infusion, 20 mg / ml.

antitumor agent - alkaloid

Concentrate for the preparation of a solution for infusions, 20 mg / 0.5 ml and 80 mg / 2 ml (complete with a solvent).

antimicrobial agent, fluoroquinolone.

Solution for infusion, 2 mg / ml.



antiallergic agent - H1-histamine receptor blocker

Tablets, film-coated (for children), 30 mg.

MIBP vaccine

Suspension for intramuscular injection 0.5 ml.

Hypolipidemic agent - inhibitor of HMG-CoA reductase

Tablets film-coated 10 mg, 20 mg and 40 mg.

hypoglycemic agent - long-acting insulin analog
Solution for subcutaneous administration, 300 units / ml.
local anesthetic

Solution for injection 40 mg / ml.

digestive enzyme
The dragees are enteric-soluble.
antimicrobial and antiprotozoal agent

Tablets, film-coated, 250 mg.

antimicrobial and antiprotozoal agent

Vaginal suppositories, 500 mg.

Tamsulosin: α1-adrenoblocker; finasteride: 5α-reductase inhibitor

A set of modified release capsules of 0.4 mg and tablets coated film coating, 5 mg.

vitamin

Capsules of prolonged action 500 mg.

Antipsychotic agent (antipsychotic).
Capsules 50 mg.

antitumor agent - alkylating compound

Concentrate for solution for infusion, 5 mg / ml.

Antimicrobial agent, nitrofuran.

Capsules 200 mg.

Treatment for alcoholism.
Tablets 500 mg.


MIBP vaccine

Suspension for intramuscular injection of 20 μg / ml.